dr. weber on side effects of dabrafenib/trametinib in melanoma
Published 6 years ago • 2.2K plays • Length 1:27Download video MP4
Download video MP3
Similar videos
-
1:46
dr. weber on dabrafenib/trametinib approval for melanoma
-
1:08
dr. weber on dabrafenib/trametinib versus vemurafenib/cobimetinib in melanoma
-
1:11
dr. weber on the fda approval of adjuvant dabrafenib/trametinib in braf-mutant melanoma
-
0:18
copy of dr. weber on the fda approval of adjuvant dabrafenib/trametinib in braf-mutant melanoma
-
0:44
dr. michael rotkowitz on dabrafenib and trametinib combination side effects
-
0:49
dr. weber on emerging therapies in melanoma
-
1:03
dr. weber on risk and benefits with immunotherapy combos in melanoma
-
2:25
dr. weber on discontinuing immunotherapy in melanoma
-
2:10
dr. weber on the toxicity profile of nivolumab versus ipilimumab for melanoma
-
2:19
dr. robert on 5-year analysis of dabrafenib/trametinib in braf v600-mutant melanoma
-
2:33
dr. sullivan discusses role of dabrafenib plus trametinib in melanoma
-
1:31
dr. daud on dabrafenib/trametinib vs immunotherapy in melanoma
-
1:24
adverse events with dabrafenib/trametinib combination in melanoma
-
1:05
dr. weber on the future of checkpoint inhibitors in melanoma
-
1:36
dr. weber on combination strategies for braf-mutant melanoma
-
1:16
dr. weber on emerging immunotherapy combinations in melanoma
-
1:19
dr. robert on potential of dabrafenib/trametinib in melanoma brain metastases
-
1:58
dr. weber on duration of checkpoint inhibitor therapy in melanoma
-
1:22
dr. weber on adjuvant pembrolizumab in melanoma